Qingqing Li
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Empowering precision public health control: a robust intelligent mask-wearing monitoring framework for complex crowd scenarios.
Journal: BMC public health
Published: March 04, 2026
Optimizing management of immune checkpoint inhibitor-induced inflammatory arthritis: A case series and literature review.
Journal: Experimental and therapeutic medicine
Published: September 02, 2025
Preserved ratio impaired spirometry and mortality in non-smoking asthma: a population-based cohort study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: July 10, 2025
Functional remodeling of iNKT cells by sulfatide-reactive type II NKT cells reprograms alveolar macrophages to alleviate lung ischemia-reperfusion injury.
Journal: Communications biology
Published: January 19, 2025
Uridine Phosphorylase 1 as a Biomarker Associated with Glycolysis in Acute Lung Injury.
Journal: Inflammation
Published: November 06, 2024
Integrated Analysis and Validation of Ferroptosis-Related Genes Associated with Ischemia/Reperfusion Injury in Lung Transplantation.
Journal: Journal of inflammation research
Published: September 02, 2024
Sequential severe immune-related adverse events induced by PD-1 inhibitor: a case report and literature review.
Journal: Frontiers in oncology
Published: February 26, 2024
FAT4 Mutation is Related to Tumor Mutation Burden and Favorable Prognosis in Gastric Cancer.
Journal: Current genomics
Published: January 21, 2024
Advances in lung ischemia/reperfusion injury: unraveling the role of innate immunity.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: October 18, 2023
A Treg-related riskscore model may improve the prognosis evaluation of colorectal cancer.
Journal: The journal of gene medicine
Published: July 12, 2023
Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review.
Journal: Frontiers in oncology
Published: June 16, 2023
Last Updated: 09/26/2026